Wisdom Ventures β Full Portfolio
14 tracked investments Β· listed companies and verified rows first
Function Health provides routine whole-body lab testing, advanced imaging, and access to top doctors to help individuals achieve preventive health awareness and disease avoidance.
Digital HealthHealthtechWellness & Fitness
Mark Hyman, M.D.(CMO)Mark Hyman(CMO)Jonathan Swerdlin(Founder)inPranitha Patil(Founder)in
Co-investors1843 CapitalAble PartnersAglae VenturesAndreessen HorowitzBattery VenturesBlue Ivy Ventures+23 more
Hume AI develops infrastructure for emotionally intelligent voice AI, providing datasets, speech models, evaluation frameworks, and human preference pipelines.
AI & Machine LearningData & InfrastructureDeveloper ToolsNew York, US
Alan Cowen(Executive Officer, Director)in
BoardJohn Beadle(Director)Janet Ho(Executive Officer)Andrew Weissman(Director)inJeffrey Kraut(Director)Marc Rubinstein(Director)
Co-investorsAegis VenturesBright Pixel CapitalComcast VenturesLG Technology VenturesMetaplanetUnion Square Ventures (USV)+2 more
Malama develops a digital health platform for managing gestational diabetes in pregnancy, providing data tracking, pattern analysis, and clinical support to reduce adverse maternal outcomes and progression to Type 2 diabetes.
Digital HealthFemTechHealthtechSan Francisco, US
Mika Eddy(Founder)Orlando Li(Founder)inDaniela Bahamon ArangoShalmali Bane
BoardVeenu Aulakh(Director)in
Co-investorsCoyote VenturesY CombinatorAcumen America
Manas AI is an AI-native biopharmaceutical company that uses neuro-symbolic foundational models to discover and develop medicines.
AI & Machine LearningBiotechDeep TechNew York, US
Siddhartha Mukherjee(Co-founder)Reid Hoffman(Co-Founder of Manas AI)inUjjwal Singh(Co-Founder & CEO)inDr. Siddhartha Mukherjee(Co-Founder & Executive Chairman)
Co-investorsGeneral CatalystBlitzscaling VenturesMosaic VenturesNext Play VenturesWestbound Equity PartnersGreylock Partners
Substack is a publishing platform that allows writers to create newsletters, cultivate audiences, and earn revenue through reader subscriptions.
Enterprise SoftwareMarketing TechMarketplacesSan Francisco, US
Chris Best(Founder/CEO)inJairaj Sethi(Founder)inHamish McKenzie(Founder/COO)in
BoardAndrew Chen(Director)in
Co-investorsConnetic VenturesFundersClubJ17 CapitalWonder VenturesY CombinatorAndreessen Horowitz+1 more
Sunnyside is a platform for building a healthier relationship with alcohol, combining a behavior-change app, human coaching over SMS and email, and a telehealth service (Sunnyside Med) through which licensed providers can prescribe compounded Naltrexone medication to reduce alcohol cravings.
ConsumerDigital HealthHealthtechSaaSWellness & FitnessLos Angeles, US
Nick Allen(Founder)inIan Andersen(Founder)
Co-investorsEudemian VenturesMotley Fool VenturesScribble VenturesV1 VCJoyance PartnersOffline Ventures+2 more
Ultralight is a GPU-accelerated HTML rendering toolkit that embeds modern web content in games and native applications across Windows, macOS, Linux, and game consoles.
Developer ToolsEnterprise SoftwareGamingHardwareSan Francisco, US
Adam Simmons(Founder & CEO)in
Co-investorsY Combinator
Ultralight is an electronic health record (EHR) system designed for clinics practicing functional, integrative, longevity, and concierge medicine.
AI & Machine LearningDigital HealthHealthtech
Pedro Tabio(Founder)in
Co-investorsValia VenturesLombardstreet Ventures
Vitalize provides an AI platform for health systems that unifies staffing, scheduling, and capacity management to optimize labor operations.
AI & Machine LearningEnterprise SoftwareHealthtechSaaSSan Francisco, US
Veeraj Shah(Founder)inSanketh Andhavarapu(Founder)in
Co-investors.406 VenturesDorm RoomMemorialCare Innovation FundY Combinator
Vitalize provides an AI platform for health systems to optimize labor management, staffing, scheduling, and operational capacity.
AI & Machine LearningEnterprise SoftwareHealthtech
Co-investorsPowerhouse VenturesDorm RoomY Combinator
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.







